| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
講演・口頭発表等 (13件)
-
中皮腫がん抗原の探索と臨床への応用.
(第1回日本石綿・中皮腫学会学術集会, ワークショップ, 2019) -
中皮腫の糖鎖修飾がん抗原を標的とする抗体医薬の開発.
(第35回日本DDS学会学術集会, 第12回日本DDS学会水島賞受賞講演 2019) -
新規ムチン様膜タンパク質・シアル化HEG1は中皮腫の高精度がんマーカーである.
(第16回 北里疾患プロテオーム研究会, 招待講演 2019) -
中皮腫特異的な糖鎖創薬の標的・HEG1に対する抗体医薬の開発.
(第9回グライコバイオロジクス研究会, 特別講演 2018) -
中皮腫の高精度診断マーカーHEG1の同定. 大阪, 2017.
(第24回石綿・中皮腫研究会, シンポジウム, 2017) -
HEG1 is a new immunohistochemical marker for the pathological diagnosis of malignant mesothelioma. The 14th International Conference of the International Mesothelioma Interest Group, Ottawa, Canada, 2018.
-
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. The 10th International Conference of the International Mesothelioma Interest Group, Kyoto, Japan, 2010.
-
Molecular structure of human and mouse intelectin-1 and comparison of binding to a mycobacterial galactofuranosyl residue. The American Association of Immunologists Annual Meeting, Boston, USA, 2006.
-
Purified constituents of BCG-CWS promote immature human dendritic cells (DC) to unique mature stages DC. 6th International Workshop on Langerhans Cells, New York, USA, 1999.
-
HEG1 is useful to distinguish malignant mesothelioma from carcinomas and selected sarcomas. USCAP 108th Annual Meeting 2019, platform presentation, National Harbor, USA, 2019.
-
HEG1 is a novel mucin-like membrane protein that is useful for the diagnosis of malignant mesothelioma. USCAP 107th Annual Meeting 2018, platform presentation, Vancouver, Canada, 2018
-
Development of early and precise diagnosis with a new mesothelioma marker HEG1. Japan-US Workshop for Cancer Research (Tokyo), Workshop presentation, Tokyo, Japan, 2018.
-
Development of precise diagnosis with a new mesothelioma marker, sialylated HEG1. The 6th Japanese Cancer Association-American Association for Cancer Research Special Joint Conference, Symposium presentation, Kyoto, Japan, 2018.
1〜13 件目 / 全 13 件
- « 最初
- ‹ 前へ
- 1
- 次へ ›
- 最後 »
